^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CCR5 expression

    i
    Other names: CCR5, C-C Motif Chemokine Receptor 5, CC-CKR-5, IDDM22, CMKBR5, CKR-5, CD195, CKR5, Chemokine (C-C Motif) Receptor 5, C-C Chemokine Receptor Type 5, HIV-1 Fusion Coreceptor, CCR-5, Chemokine (C-C Motif) Receptor 5 (Gene/Pseudogene), C-C Motif Chemokine Receptor 5 (Gene/Pseudogene), C-C Motif Chemokine Receptor 5 A159A, Chemokine Recptor CCR5 Delta32, Chemokine Receptor CCR5, CD195 Antigen, C-C CKR-5, Chemr13, CHEMR13, CCCKR5
    Entrez ID:
    1234
    Related biomarkers:
    Expression
    over2years
    "Cancers w/ highest CCR5 expression are priority candidates for further analysis & clinical trial engagement" ... How does this jive w/ TNBC having the lowest 💰Incelldx LICENSED💰 "H score" but being put forth as Cytodyn's golden egg profit opportunity? Who protects PATIENTS??? (@IamBreastCancer)
    Clinical
    |
    CCR5 (C-C Motif Chemokine Receptor 5)
    |
    CCR5 expression
    over2years
    Well you just disproved the point you were trying to make. With the great results seen from the TNBC study, with the lower CCR5 expression. Leronlimab should be a home run for the majority of the cancers on this list. Which have a higher CCR5 expression. (@William33308264)
    CCR5 (C-C Motif Chemokine Receptor 5)
    |
    CCR5 expression
    |
    Vyrologix (leronlimab)